Joel A Sincavage

Array ( [id] => 4419007 [patent_doc_number] => 06177273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Antisense modulation of integrin-linked kinase expression' [patent_app_type] => 1 [patent_app_number] => 9/428219 [patent_app_country] => US [patent_app_date] => 1999-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23227 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177273.pdf [firstpage_image] =>[orig_patent_app_number] => 428219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265923 [patent_doc_number] => 06306656 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Plant embryo--and aleurone--specific promoter' [patent_app_type] => 1 [patent_app_number] => 9/417286 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3889 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306656.pdf [firstpage_image] =>[orig_patent_app_number] => 417286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4166741 [patent_doc_number] => 06140042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'TAB1 protein and DNA coding therefore' [patent_app_type] => 1 [patent_app_number] => 9/406854 [patent_app_country] => US [patent_app_date] => 1999-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10491 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 348 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140042.pdf [firstpage_image] =>[orig_patent_app_number] => 406854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1404673 [patent_doc_number] => 06538176 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Maize replication protein A and use' [patent_app_type] => B1 [patent_app_number] => 09/396149 [patent_app_country] => US [patent_app_date] => 1999-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 33312 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538176.pdf [firstpage_image] =>[orig_patent_app_number] => 09396149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4214524 [patent_doc_number] => 06087173 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Antisense modulation of X-linked inhibitor of apoptosis expression' [patent_app_type] => 1 [patent_app_number] => 9/392580 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26496 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087173.pdf [firstpage_image] =>[orig_patent_app_number] => 392580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401157 [patent_doc_number] => 06531584 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => '2\'modified oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 09/389283 [patent_app_country] => US [patent_app_date] => 1999-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31435 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531584.pdf [firstpage_image] =>[orig_patent_app_number] => 09389283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322735 [patent_doc_number] => 06331526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/389855 [patent_app_country] => US [patent_app_date] => 1999-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 12445 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331526.pdf [firstpage_image] =>[orig_patent_app_number] => 389855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631459 [patent_doc_number] => 06635473 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Polypeptides and polynucleotides from coagulase-negative staphylococci' [patent_app_type] => B1 [patent_app_number] => 09/386962 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 21 [patent_no_of_words] => 34145 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635473.pdf [firstpage_image] =>[orig_patent_app_number] => 09386962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484814 [patent_doc_number] => 06365374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => '2-deoxy-2-alkylnucleotide containing nucleic acid' [patent_app_type] => B1 [patent_app_number] => 09/376687 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11591 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365374.pdf [firstpage_image] =>[orig_patent_app_number] => 09376687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1582481 [patent_doc_number] => 06423885 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Methods for obtaining modified phenotypes in plant cells' [patent_app_type] => B1 [patent_app_number] => 09/373720 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13214 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423885.pdf [firstpage_image] =>[orig_patent_app_number] => 09373720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240266 [patent_doc_number] => 06166182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Human neurotensin receptor type 2 and splice variants thereof' [patent_app_type] => 1 [patent_app_number] => 9/372498 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11129 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166182.pdf [firstpage_image] =>[orig_patent_app_number] => 372498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 774248 [patent_doc_number] => 07002003 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Method for the inhibition of function of STAT transcription factors' [patent_app_type] => utility [patent_app_number] => 09/744875 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8868 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/002/07002003.pdf [firstpage_image] =>[orig_patent_app_number] => 09744875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221679 [patent_doc_number] => 06010906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Antisense modulation of Jun N-terminal kinase kinase-1 expression' [patent_app_type] => 1 [patent_app_number] => 9/358382 [patent_app_country] => US [patent_app_date] => 1999-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26487 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010906.pdf [firstpage_image] =>[orig_patent_app_number] => 358382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4136176 [patent_doc_number] => 06015712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Antisense modulation of FADD expression' [patent_app_type] => 1 [patent_app_number] => 9/357072 [patent_app_country] => US [patent_app_date] => 1999-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27481 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015712.pdf [firstpage_image] =>[orig_patent_app_number] => 357072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736033 [patent_doc_number] => 20030013668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDES TARGETED TO IL-15' [patent_app_type] => new [patent_app_number] => 09/349216 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8718 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013668.pdf [firstpage_image] =>[orig_patent_app_number] => 09349216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589874 [patent_doc_number] => 06482933 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Molecules of the card-related protein family and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/340620 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 62 [patent_no_of_words] => 83605 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482933.pdf [firstpage_image] =>[orig_patent_app_number] => 09340620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1397373 [patent_doc_number] => 06537804 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growth' [patent_app_type] => B1 [patent_app_number] => 09/101059 [patent_app_country] => US [patent_app_date] => 1999-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 33 [patent_no_of_words] => 30334 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537804.pdf [firstpage_image] =>[orig_patent_app_number] => 09101059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550882 [patent_doc_number] => 06399586 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Modified VEGF oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 09/320911 [patent_app_country] => US [patent_app_date] => 1999-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11739 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399586.pdf [firstpage_image] =>[orig_patent_app_number] => 09320911 [rel_patent_id] =>[rel_patent_doc_number] =>)